bye bye traders. I might be stupid but for this MC the potential is HUGE as I see it and progress is clearly being made. Analytics revenue is going to grow strongly over coming quarters, working capital to see us at least through the promarker commercialisation, great partnerships with pharmaceutical coys leading to possible licenses and potential new biomarker discoveries initially in lung conditions and who knows what else will be a rinse and repeat proposition. I don't think the market gets PIQs disruptive biomarker discovery technology.
Ann: Appendix 4C - December 2017 Quarterly Report, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $187.1K | 634.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 81754 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |